Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer

被引：7
|
作者：
Telli, Melinda L. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 29期
关键词：
III RANDOMIZED GEPARTRIO; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; THERAPY; TRIAL; CYCLOPHOSPHAMIDE; PACLITAXEL; EPIRUBICIN;
D O I：
10.1200/JCO.2013.51.0313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3613 / 3615
页数：3
相关论文
共 50 条
  • [41] Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
    Negrao, Erika M. S.
    Souza, Juliana A.
    Marques, Elvira F.
    Bitencourt, Almir G., V
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 120
  • [42] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [43] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
  • [44] should radiotherapy be avoided after neoadjuvant chemotherapy in complete response breast cancer?
    Arenas Prat, M.
    Sabater, S.
    Bonet, M.
    Gascon, M.
    Gomez, D.
    Arquez, M.
    Torres, L.
    Gomez, J.
    Amillano, K.
    Mele, M.
    De la Flor, M.
    Rodriguez, E.
    Camps, J.
    Joven, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1271 - S1271
  • [45] Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer
    Le Bouëdec, G
    Charrier, S
    Curé, H
    de Latour, MP
    Ferrière, JP
    Chollet, P
    Dauplat, J
    PRESSE MEDICALE, 1999, 28 (39): : 2145 - 2148
  • [46] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [47] Demographic Determinants of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
    Anderson, Lisa
    Daniele, Karla
    Hayes, Madison
    Dancel, Canice Lei
    Dhanasekara, Samudani
    Rahman, Rakhshanda
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S383 - S384
  • [48] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [49] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
    Cordoba Ortega, J. F.
    Gasol Cudos, A.
    Morales Murillo, S.
    Vilardell Villellas, F.
    Siso Raber, C.
    Canosa Morales, C.
    Salud Salvia, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
  • [50] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
12345